Company / Current Liabilities
Lipocine Inc. Current Liabilities History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$2.5M
FY2025
5-year range
$1.5M / $5.6M
FY2021-FY2025
Trend
+67.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 9 years, ranging from $1M in FY2013 to $7M in FY2020.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of -17.4%.
Improved from $3M to $3M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +14.6%
- 5-Year CAGR
- -17.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -17.4%, indicating a declining trend.
- In FY2025, current liabilities increased 67.1% year-over-year.
- Peak current liabilities was recorded in FY2020.
- Lowest current liabilities in the period was in FY2013.
Company context
Key Data Points
- Altman Z-Score -1.16 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.5M | +67.1% |
| FY2024 | $1.5M | -42.5% |
| FY2023 | $2.6M | +56.8% |
| FY2022 | $1.7M | -70.1% |
| FY2021 | $5.6M | -14.7% |
| FY2020 | $6.6M | +32.6% |
| FY2019 | $5.0M | +10.5% |
| FY2018 | $4.5M | +249.9% |
| FY2013 | $1.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026